Byung Kwan Park
Papers
2
Total Citations
88
H-Index
2
About
Byung Kwan Park is a leading urologic oncologist whose work has reshaped surgical approaches to prostate and kidney cancers. His research centers on optimizing functional outcomes after robotic-assisted radical prostatectomy (RARP) and comparing minimally invasive treatments for renal cell carcinoma. In a landmark 2017 study, Park demonstrated that preoperative and postoperative membranous urethral length (MUL), measured by 3 Tesla MRI, is a critical predictor of urinary continence recovery after RARP—a finding that has guided surgeons in patient counseling and nerve-sparing techniques. This work, cited 52 times, has become foundational in prostate cancer surgery. Park also conducted a pivotal propensity score-matched comparison of radiofrequency ablation (RFA) versus robotic partial nephrectomy for T1a renal cell carcinoma, showing comparable mid-term oncologic outcomes. This 2018 study, with 36 citations, provides crucial evidence for treatment selection in small renal masses. By integrating advanced imaging and comparative effectiveness research, Park has directly improved patient quality of life and surgical decision-making, establishing himself as a key figure in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2